| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Beck J, Morgan PA |
Designer drug confusion: a focus on MDMA |
J Drug Educ |
1986 |
| Schechter MD |
Discriminative profile of MDMA |
Pharmacol Biochem Be... |
1986 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Gold LH, Koob GF |
Methysergide potentiates the hyperactivity produced by MDMA in rats |
Pharmacol Biochem Be... |
1988 |
| Mamounas LA, Molliver ME |
Evidence for dual serotonergic projections to neocortex: axons from th... |
Exp Neurol |
1988 |
| Oberlender R, Nichols DE |
Drug discrimination studies with MDMA and amphetamine |
Psychopharmacology (... |
1988 |
| Peroutka SJ, Newman H, Ha... |
Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... |
Neuropsychopharmacol... |
1988 |
| Schechter MD |
Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... |
Pharmacol Biochem Be... |
1988 |
| Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
| Gold LH, Geyer MA, Koob G... |
Psychostimulant properties of MDMA |
NIDA Res Monogr |
1989 |
| Gold LH, Geyer MA, Koob G... |
Neurochemical mechanisms involved in behavioral effects of amphetamine... |
NIDA Res Monogr |
1989 |
| Gold LH, Hubner CB, Koob ... |
A role for the mesolimbic dopamine system in the psychostimulant actio... |
Psychopharmacology (... |
1989 |
| Gold LH, Koob GF |
MDMA produces stimulant-like conditioned locomotor activity |
Psychopharmacology (... |
1989 |
| Nichols DE, Oberlender R |
Structure-activity relationships of MDMA-like substances |
NIDA Res Monogr |
1989 |
| Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Evans SM, Zacny JP, Johan... |
Three-choice discrimination among (+)-amphetamine, fenfluramine and sa... |
Pharmacol Biochem Be... |
1990 |
| Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
| Hekmatpanah CR, Peroutka ... |
5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... |
Eur J Pharmacol |
1990 |
| Nichols DE, Oberlender R |
Structure-activity relationships of MDMA and related compounds: a new ... |
Ann N Y Acad Sci |
1990 |
| Oberlender R, Nichols DE |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... |
J Pharmacol Exp Ther |
1990 |
| Teitler M, Leonhardt S, A... |
Receptor pharmacology of MDMA and related hallucinogens |
Ann N Y Acad Sci |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Bilsky EJ, Hubbell CL, De... |
MDMA produces a conditioned place preference and elicits ejaculation i... |
Pharmacol Biochem Be... |
1991 |
| Garrett ER, Seyda K, Marr... |
High performance liquid chromatographic assays of the illicit designer... |
Acta Pharm Nord |
1991 |
| Johnson MP, Conarty PF, N... |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... |
Eur J Pharmacol |
1991 |
| Paulus MP, Geyer MA |
A temporal and spatial scaling hypothesis for the behavioral effects o... |
Psychopharmacology (... |
1991 |
| Schifano F |
Chronic atypical psychosis associated with MDMA ('ecstasy') abuse |
Lancet |
1991 |
| Gouzoulis E, Steiger A, E... |
Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... |
Biol Psychiatry |
1992 |
| Callaway CW, Geyer MA |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... |
Eur J Pharmacol |
1992 |
| Herndon JL, Pierson ME, G... |
Mechanistic investigation of the stimulus properties of 1-(3-trifluoro... |
Pharmacol Biochem Be... |
1992 |
| Johnson M, Elayan I, Hans... |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... |
J Pharmacol Exp Ther |
1992 |
| Kehne JH, McCloskey TC, T... |
Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (... |
J Pharmacol Exp Ther |
1992 |
| Solowij N, Hall W, Lee N |
Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and thei... |
Br J Addict |
1992 |
| Zhao ZY, Castagnoli N Jr,... |
Synthesis and neurotoxicological evaluation of putative metabolites of... |
Chem Res Toxicol |
1992 |
| Heilig, Steve |
MDMA Update: The Science and Politics of Ecstasy |
Newsletter of the Ca... |
1993 |
| Stolaroff MJ, Wells CW |
Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 |
Yearbook for Ethnome... |
1993 |
| Krebs KM, Geyer MA |
Behavioral characterization of alpha-ethyltryptamine, a tryptamine der... |
Psychopharmacology (... |
1993 |
| Robinson TE, Castaneda E,... |
Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... |
Neuropsychopharmacol... |
1993 |
| Schechter MD, Gordon TL |
Comparison of the behavioral effects of ibogaine from three sources: m... |
Eur J Pharmacol |
1993 |
| Schuldiner S, Steiner-Mor... |
Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... |
Mol Pharmacol |
1993 |
| McDowell DM, Kleber HD |
MDMA: Its history and pharmacology |
Psychiatric Annals |
1994 |
| Bronson ME, Barrios-Zambr... |
Behavioral and developmental effects of two 3,4-methylenedioxymethamph... |
Drug Alcohol Depend |
1994 |
| Leonardi ETK, Azmitia EC |
MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with f... |
Neuropsychopharmacol... |
1994 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Miller DB, O'Callaghan JP |
The role of temperature, stress, and other factors in the neurotoxicit... |
Mol Neurobiol |
1995 |
| Premkumar LS, Ahern GP |
Blockade of a resting potassium channel and modulation of synaptic tra... |
J Pharmacol Exp Ther |
1995 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Marona-Lewicka D, Rhee GS... |
Reinforcing effects of certain serotonin-releasing amphetamine derivat... |
Pharmacol Biochem Be... |
1996 |
| Miller DB, O'Callaghan JP |
Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interac... |
Ann N Y Acad Sci |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Lin HQ, Jackson DM, Atren... |
Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-el... |
Brain Res |
1997 |
| Crespi D, Mennini T, Gobb... |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induc... |
Br J Pharmacol |
1997 |
| Taraska T, Finnegan KT |
Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-met... |
J Pharmacol Exp Ther |
1997 |
| Schwartz RH, Miller NS |
MDMA (ecstasy) and the rave: a review |
Pediatrics |
1997 |
| Baker LE, Taylor MM |
Assessment of the MDA and MDMA optical isomers in a stimulant-hallucin... |
Pharmacol Biochem Be... |
1997 |
| Glennon RA, Young R, Duka... |
Initial characterization of PMMA as a discriminative stimulus |
Pharmacol Biochem Be... |
1997 |
| Schechter MD |
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-... |
Life Sci |
1997 |
| Zheng Y, Laverty R |
Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (... |
Brain Res |
1998 |
| Connor TJ, McNamara MG, F... |
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces ... |
Immunopharmacology |
1998 |
| Bilsky EJ, Montegut MJ, N... |
CGS 10746B, a novel dopamine release inhibitor, blocks the establishme... |
Pharmacol Biochem Be... |
1998 |
| Jansen KL, Forrest AR |
Toxic effect of MDMA on brain serotonin neurons |
Lancet |
1999 |
| Hamilton J, Balint P, Fie... |
A concealed cause of recurrent renal failure in a patient with juvenil... |
Ann Rheum Dis |
1999 |
| Laviola G, Adriani W, Ter... |
Psychobiological risk factors for vulnerability to psychostimulants in... |
Neurosci Biobehav Re... |
1999 |
| Lin HQ, Burden PM, Christ... |
The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the... |
Pharmacol Biochem Be... |
1999 |
| Pacifici R, Zuccaro P, Fa... |
Immunomodulating properties of MDMA alone and in combination with alco... |
Life Sci |
1999 |
| van Aerts LAGJM, Malleret... |
N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties ... |
Addiction Biology |
2000 |
| Aalberg L, DeRuiter J, No... |
Chromatographic and Mass Spectral Methods of Identification for the Si... |
J Chromatogr Sci |
2000 |
| Cami J, Farre M, et al |
Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... |
J Clin Psychopharmac... |
2000 |
| Johnson EA, Sharp DS, Mil... |
Restraint as a stressor in mice: against the dopaminergic neurotoxicit... |
Brain Res |
2000 |
| Maldonado E, Navarro JF |
Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mic... |
Prog Neuropsychophar... |
2000 |
| Sharma R, Nelson LS |
Methylenedioxymethamphetamine (MDMA) induced hyponatremia |
Int J Med Toxicol |
2000 |
| Connor TJ, Dennedy MC, Ha... |
Methylenedioxymethamphetamine-induced suppression of interleukin-1beta... |
Eur J Pharmacol |
2001 |
| Maldonado E, Navarro JF |
Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encoun... |
Pharmacological Rese... |
2001 |
| Kalant, H |
The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs |
Canadian Medical Ass... |
2001 |
| Logan BK, Couper FJ |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairme... |
J Forensic Sci |
2001 |
| Teter CJ, Guthrie SK |
A comprehensive review of MDMA and GHB: two common club drugs |
Pharmacotherapy |
2001 |
| Leshner AI |
What should the public be told about the risks of Ecstasy? |
JAMA |
2002 |
| Glennon RA, Young R, Rang... |
Further characterization of the stimulus properties of 5,6,7,8- tetrah... |
Pharmacol Biochem Be... |
2002 |
| Szabo Z, McCann UD, Wilso... |
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... |
J Nucl Med |
2002 |
| Anonymous |
Ecstasy [a brief introduction] |
Psychiatric Services... |
2002 |
| Gobbi M, Moia M, Pirona L... |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neur... |
J Neurochem |
2002 |
| Jiang XR, Dryhurst G |
Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehyd... |
Chem Res Toxicol |
2002 |
| Kelly PA, Ritchie IM, Qua... |
Functional consequences of perinatal exposure to 3,4-methylenedioxymet... |
Br J Pharmacol |
2002 |
| Riba J, Rodriguez-Fornel... |
Effects of ayahuasca on sensory and sensorimotor gating in humans as m... |
Psychopharmacology (... |
2002 |
| Pizarro N, Llebaria A, Ca... |
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its m... |
Rapid Commun Mass Sp... |
2003 |
| Cole JC, Sumnall HR, O'Sh... |
Effects of MDMA exposure on the conditioned place preference produced ... |
Psychopharmacology (... |
2003 |
| Goodwin AK, Pynnonen DM, ... |
Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus ... |
Pharmacol Biochem Be... |
2003 |
| Mlinar B, Corradetti R |
Endogenous 5-HT, released by MDMA through serotonin transporter- and s... |
Eur J Neurosci |
2003 |
| Salzmann J, Marie-Claire ... |
Importance of ERK activation in behavioral and biochemical effects ind... |
Br J Pharmacol |
2003 |
| de la Torre R, Farre M, R... |
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposit... |
Ther Drug Monit |
2004 |
| Bubar MJ, Pack KM, Franke... |
Effects of dopamine D(1)- or D(2)-like receptor antagonists on the hyp... |
Psychopharmacology (... |
2004 |
| Johnson EA, O\'Callaghan ... |
Brain concentrations of d-MDMA are increased after stress |
Psychopharmacology (... |
2004 |
| Pizarro N, Farre M, Pujad... |
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its m... |
Drug Metab Dispos |
2004 |
| Sala M, Braida D |
Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interact... |
Pharmacol Biochem Be... |
2005 |
| Kehr J, Ichinose F, Yoshi... |
Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increa... |
Br J Pharmacol |
2011 |
| Parrott AC |
Residual neurocognitive features of ecstasy use: a re-interpretation o... |
Addiction |
2011 |
| Hill SL, Thomas SH |
Clinical toxicology of newer recreational drugs |
Clin Toxicol (Phila) |
2011 |
